Weight loss drug semaglutide linked to better heart health 14 May 2024 The weight loss drug semaglutide delivers cardiovascular benefits irrespective of starting weight and amount of weight lost, according to preliminary findings from a UCL-led research team
Semaglutides interaction with the body can lead to muscle cramps through various biological processes
More importantly, we understand the psychological and social aspects of weight without shame or judgment
Figure S19
Statements Author contributions SS: Visualization, Writing review & editing, Investigation, Writing original draft, Conceptualization, Funding acquisition
The results of the clinical trials that have examined the effects of selenium supplementation on thyroid autoimmunity in pregnant women have also been controversial [84, 85], and the latest ATA guidelines recommends against selenium supplementation in pregnant women [86]